Removing one carotid body from some patients with high blood pressure can provide immediate and sustained fall in blood pressure, finds a new study.
Carotid bodies, a small cluster of chemoreceptors and supporting cells located near the fork (bifurcation) of the carotid artery that feed the brain with blood, appear to be a cause of high blood pressure.
"The falls in blood pressure are impressive -- more than pharmacological medication -- and demonstrate the potential for targeting the carotid body to treat hypertension," said Angus Nightingale, researcher at the University of Bristol, England.
The carotid bodies detect the levels of oxygen in blood and when this falls they raise the alarm of a potential emergency by signalling to the brain to increase breathing and blood pressure.
"Treating the carotid body is a novel approach and a potential game changer as we believe we are reducing one of the main causes for hypertension in many patients. High blood pressure treatment typically tackles the symptoms targeting the end organs such as the heart, kidneys and blood vessels, and not the causes," said Julian Paton, researcher at the University of Bristol, England.
The clinical trial demonstrated that the carotid bodies in patients who responded to resection had raised carotid body activity. These patients breathed more at rest and produced exaggerated breathing responses when the oxygen level in their blood was lowered.
"Although this surgical approach to controlling high blood pressure was successful, we don't think this will be the solution in the long term. We now need to find a drug that dampens down an overactive carotid body and resets the blood pressure thermostat to a normal level," Nightingale added.
The research study was published recently in the Journal of American College of Cardiology: Basic to Translational Science.
--IANS
som/ss/vt
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
